Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Long-Term Investments (2018)

Akebia Therapeutics (AKBA) has disclosed Long-Term Investments for 1 consecutive years, with $245000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Long-Term Investments changed N/A to $245000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $245000.0, a N/A change, with the full-year FY2018 number at $245000.0, changed N/A from a year prior.
  • Long-Term Investments was $245000.0 for Q4 2018 at Akebia Therapeutics.
  • In the past five years, Long-Term Investments ranged from a high of $245000.0 in Q4 2018 to a low of $245000.0 in Q4 2018.